Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

NCT00005906 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00005906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2000
Completion date
Not reported
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites, lymphangioleiomyomatosis, lymphangiomyomas, pleural effusions